During the past decade, Parkdale Medical Centre conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Parkdale Medical Centre" are "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Parkdale Medical Centre" in a lesser frequency.

Most popular intervention types in "Parkdale Medical Centre" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Parkdale Medical Centre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Parkdale Medical Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Parkdale Medical Centre, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Parkdale Medical Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".